Comparable stake leader
ALPHA CAPITAL ANSTALT
SEC ownership of ENvue Medical, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001326706.
Disclosed value leader
BANK OF AMERICA CORP /DE/
Comparable rows
16/25
Latest evidence
30 Jun 2026
- Public ticker
- FEED on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
ALPHA CAPITAL ANSTALT
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
16 of 25
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
ALPHA CAPITAL ANSTALT
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001326706
- Issuer location
- Tyler, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ENvue Medical, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ALPHA CAPITAL ANSTALT
Disclosed value leader
BANK OF AMERICA CORP /DE/
Comparable rows
16/25
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
9 rows are not safely comparable across share classes.
13D/G row: ALPHA CAPITAL ANSTALT
Showing 1-8 of 25 holder rows.
Quick read
ALPHA CAPITAL ANSTALT leads the comparable SEC ownership view at 10%.
16 of 25 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ALPHA CAPITAL ANSTALT's linked filing trail.
Comparable ownership
Top 5
ALPHA CAPITAL ANSTALT
10%
ARMISTICE CAPITAL, LLC
5%
BANK OF AMERICA CORP /DE/
0%
HRT FINANCIAL LP
11%
Virtu Financial LLC
8.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 25 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ALPHA CAPITAL ANSTALT |
13D/G
|
10%
|
$305,967
82,471 shares
|
$0 | 16 May 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$147,947
39,878 shares
|
$0 | 31 Mar 2025 |
| BANK OF AMERICA CORP /DE/ |
3/4/5
13D/G
10%+ Owner
|
0%
from 13D/G
|
$704,970
231,138 shares
|
-$8,906 | 02 Feb 2026 |
| HRT FINANCIAL LP |
13F
Company
|
11%
|
$59,000
115,579 shares
|
— | 30 Jun 2026 |
| Virtu Financial LLC |
13F
Company
|
8.7%
|
$49,000
95,296 shares
|
— | 30 Jun 2026 |
| JANE STREET GROUP, LLC |
13F
Company
|
3.5%
|
$19,382
37,635 shares
|
— | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.4%
|
$7,964
15,466 shares
|
— | 30 Jun 2026 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0.94%
|
$5,294
10,279 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$487,414.
Buys
$640,800
Insiders: 1
Sells
$153,386
Insiders: 2
Net
+$487,414
Shares: +27,082
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 240,000
Shares: 212,918
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 210,000 | $0 | $144,480 | -$144,480 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 240,000 | 2,918 | $640,800 | $8,906 | +$631,894 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-16 of 16 reporting-owner rows connected to ENvue Medical, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
16
Largest Forms 3/4/5 holder
BANK OF AMERICA CORP /DE/
Net 12M change
+$487,414
Latest report
22 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 10%+ Owner | $704,970 | -$8,906 | -1.2% | Filing P/S | 02 Feb 2026 |
| Christian Michael Glibert | No longer subject to section 1 | $0 | +$496,320 | Mixed | 22 Jun 2026 | |
| Nicole M. Fernandez-McGovern | Interim CFO | Mixed | 18 Dec 2025 | |||
| Alison Burgett | Director | Mixed | 04 Dec 2025 | |||
| Zeev Jhoshua Rotstein | Director | Mixed | 14 Feb 2025 | |||
| Aurora Cassirer | Director | Mixed | 30 Dec 2024 | |||
| Michael Ferguson | Director | Mixed | 30 Dec 2024 | |||
| Martin M. Goldstein | Director | Mixed | 30 Dec 2024 | |||
| Brian M. Murphy | Chief Executive Officer, Director | Mixed | 30 Dec 2024 | |||
| Stephen R. Brown | Chief Financial Officer | Mixed | 30 Dec 2024 | |||
| Christopher M. Fashek | Director | Mixed | 30 Dec 2024 | |||
| Maria Schroeder | Director | Mixed | 30 Dec 2024 | |||
| David Ian Johnson | Director | Mixed | 04 Dec 2025 | |||
| Pellegrino Pionati | Director | Mixed | 04 Dec 2025 | |||
| Thomas Mika | Director | Mixed | 30 Dec 2024 | |||
| Harold Jacob MD | Chief Medical Officer, Director | Mixed | 30 Dec 2024 |
Recent insider transactions for ENvue Medical, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Christian Michael Glibert | $FEED | Common Stock | Sale | -100% | $144,480 | $0.6880 | -210,000 | 0 | 22 Jun 2026 | Direct |
| Christian Michael Glibert | FEED | Common Stock | Other | 0 | 240,000 | 15 Apr 2026 | Direct | |||
| Bank Of America Corp /De/ | FEED | Common Stock | Sale | -1.25% | $8,906 | $3.05 | -2,918 | 231,138 | 02 Feb 2026 | See Footnotes |
| Christian Michael Glibert | FEED | Common Stock, par value $0.001 per share | Purchase | $640,800 | $2.67 | 240,000 | 240,000 | 14 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.